ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 167 filers reported holding ALLAKOS INC in Q1 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 2,268,188 | $184,744,000 | 7.82% |
| Fairmount Funds Management LLC | 164,662 | $13,412,000 | 5.68% |
| Samsara BioCapital, LLC | 192,334 | $15,666,000 | 4.37% |
| Redmile Group, LLC | 2,425,560 | $197,562,000 | 3.63% |
| Boxer Capital, LLC | 675,000 | $54,979,000 | 1.90% |
| Rock Springs Capital Management LP | 241,582 | $19,677,000 | 0.50% |
| Handelsinvest Investeringsforvaltning | 30,000 | $2,444,000 | 0.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $1,279,000 | 0.41% |
| Eventide Asset Management | 160,000 | $13,032,000 | 0.26% |
| Cormorant Asset Management, LP | 75,000 | $6,109,000 | 0.24% |